Europäische Kommission erteilt Zulassung für Depemokimab in zwei Indikationen

Allergo Journal 2026

View at publisher
Authors: Redaktion Facharztmagazine
DOI: 10.1007/s15007-026-6651-3
Cited by: 0

Fields of Study & Subjects

Allergic Rhinitis and Sensitization Asthma and respiratory diseases Dermatology and Skin Diseases

Publication details

Journal / source
Allergo Journal
Volume
35
Issue
2
Pages
53–53
Publication date
1 March 2026
Language
DE